New Retina Radio
New Retina Radio

02.23.23

The Era of Geographic Atrophy Treatment Begins

The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for patients with geographic atrophy. Allen C. Ho, MD, and Robert L. Avery, MD, share their initial reactions to the approval and discuss the potential effect on patient care and clinical practice. 

View full description +

MORE EPISODES

01.15.26

New Retina Radio Journal Club w/ VBS: Diagnosis Delays in Stargardt Disease

Alexis Warren, MD; Jesse Sengillo, MD; and Sruthi Arepalli, MD

01.08.26

The Fellow Eye: Episode 1

David Fell MD; Justin Muste, MD; Flavius Beca, MD

12.18.25

New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates

Nikisha Kothari, MD; Jesse Sengillo, MD; and Nicholas Farber, MD

12.09.25

DME, DR, and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

12.09.25

Wet AMD and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 3 of 3)

Jay Sridhar, MD; Durga Borkar, MD, MMCi; and Christina Weng, MD, MBA

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 2 of 3)

Jay Sridhar, MD; Maggie Runner, MD; and Veeral Sheth, MD, MBA

12.04.25

Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 1 of 3)

Jay Sridhar, MD; Danny Mammo, MD; and David Sarraf, MD

Show More